articleMolecular TherapyMar 22, 2011HYBRID OA

Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice

Yale University · Mirna Therapeutics (United States)

PubMed
Indexed incrossrefpubmed

Abstract

MicroRNAs (miRNAs) are emerging as potential cancer therapeutics, but effective delivery mechanisms to tumor sites are a roadblock to utility. Here we show that systemically delivered, synthetic miRNA mimics in complex with a novel neutral lipid emulsion are preferentially targeted to lung tumors and show therapeutic benefit in mouse models of lung cancer. Therapeutic delivery was demonstrated using mimics of the tumor suppressors, microRNA-34a (miR-34a) and let-7, both of which are often down regulated or lost in lung cancer. Systemic treatment of a Kras-activated autochthonous mouse model of non-small cell lung cancer (NSCLC) led to a significant decrease in tumor burden. Specifically, mice treated with…

Citation impact

657
total citations
FWCI
27.48
Percentile
100%
References
34
Citations per year

Authors

9

Topics & keywords

Keywords
  • microRNA
  • Lung cancer
  • KRAS
  • Cancer research
  • Suppressor
  • Cancer
  • Lung
  • Medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding